Manometry in Motility Disorders

Diagnosis and Management of Esophageal Motility Disorders

Introduction
This protocol provides a standardized, evidence-based framework for the diagnosis and management of esophageal motility disorders, grounded in the Chicago Classification v4.0. Its purpose is to equip gastroenterology fellows with a systematic approach to patient care, beginning with initial symptom evaluation and progressing through advanced diagnostic interpretation and therapeutic decision-making. By following this structured pathway, fellows can build the clinical reasoning necessary to navigate this complex field with confidence and precision.

1.0 Initial Patient Evaluation and Diagnostic Sequencing
A structured initial evaluation is strategically paramount in patients with suspected esophageal motor dysfunction. Before proceeding to specialized motility testing, clinicians must first systematically exclude structural, malignant, and inflammatory causes of esophageal symptoms. This critical step is essential to avoid misdiagnosis, prevent therapeutic errors, and ensure that definitive motility testing is applied to the appropriate patient population.
The stepwise diagnostic approach for a patient presenting with symptoms suggestive of an esophageal motility disorder is as follows:

Patient Presentation & Identification of Alarm Features
Patients typically present with core symptoms such as dysphagia (difficulty swallowing, which can be to liquids, solids, or both), non-cardiac chest pain, refractory reflux symptoms, or regurgitation of undigested food. The presence of any of the following alarm features mandates an immediate upper endoscopy:
Alarm Features:
  • Significant weight loss
  • Anemia
  • Overt gastrointestinal bleeding
  • Progressive, worsening symptoms
  • New onset of symptoms in a patient over age 50

First-Line Investigation: Upper Endoscopy (EGD)
An EGD is the mandatory first-line investigation for any patient with dysphagia or other alarm features. Its primary purpose is to rule out structural pathology, including strictures, rings, webs, malignancy (pseudoachalasia), and eosinophilic esophagitis. While the primary goal is exclusion, secondary findings such as retained food, saliva, or a puckered esophagogastric junction (EGJ) may suggest an underlying motility disorder. The guiding principle remains: "Achalasia isn't achalasia until you scope it."

Second-Line Investigation: Barium Esophagram
Following an unrevealing EGD, a barium esophagram is often the next logical step. This radiographic study is highly valuable for identifying classic patterns associated with specific motor disorders. A timed barium esophagram can further assess esophageal function by measuring contrast clearance at one, two, and five minutes.

Definitive Diagnostic Test: High-Resolution Manometry (HRM)
HRM is the gold standard for definitively diagnosing and classifying esophageal motility disorders. It is indicated for patients with dysphagia and a normal EGD, for those with suspected motility issues based on a barium swallow, or for evaluating refractory GERD symptoms after structural and inflammatory causes have been excluded.

Adjunctive Testing: EndoFLIP
The Functional Lumen Imaging Probe (EndoFLIP) is an adjunctive technology performed during endoscopy to evaluate the distensibility of the esophagogastric junction. It provides complementary data to support a diagnosis of achalasia or EGJ outflow obstruction (EGJOO) but is not a replacement for HRM as the primary diagnostic tool.
Once structural etiologies have been thoroughly excluded and an indication for HRM is established, a systematic interpretation of the manometric data using the Chicago Classification framework is required to arrive at a precise diagnosis.

2.0 High-Resolution Manometry (HRM) Interpretation: The Chicago v4.0 Framework
The Chicago Classification v4.0 provides the objective, standardized framework for interpreting HRM studies, ensuring a consistent and reproducible diagnostic approach. This framework is built upon a hierarchical analysis of three core manometric metrics that evaluate lower esophageal sphincter relaxation, peristaltic vigor, and peristaltic timing.

The Three Core Manometry Metrics:
Integrated Relaxation Pressure (IRP): The IRP is the primary measure of EGJ relaxation following a swallow. An elevated IRP is the hallmark of impaired EGJ relaxation and points toward a disorder on the achalasia or EGJ outflow obstruction (EGJOO) spectrum.
Distal Contractile Integral (DCI): The DCI measures the vigor, or strength, of the esophageal body contraction. Its value (measured in mmHg·cm·s) categorizes peristalsis along a spectrum:
  • Greater than 8000: Hypercontractile
  • 450–8000: Normal
  • Less than 450: Weak/Ineffective
  • Less than 100 (or ~0): Absent/Failed
Distal Latency (DL): The DL measures the timing of the peristaltic wave, specifically the interval from the start of the swallow to the arrival of the contractile wave in the distal esophagus. A DL < 4.5 seconds is defined as a "premature contraction" and is the pathognomonic finding of distal esophageal spasm.

The Diagnostic Logic of the Chicago Classification:
The Chicago Classification follows a clear, hierarchical algorithm:

Step 1: Analyze LES Relaxation (IRP). The first and most critical step is to evaluate the IRP. An elevated IRP immediately places the patient on the spectrum of EGJ outflow disorders (achalasia or EGJOO). A normal IRP rules out these conditions and directs the analysis toward disorders of peristalsis.
Step 2: Analyze Peristaltic Timing (DL) [if IRP is normal]. If the IRP is normal, the next step is to assess the timing of contractions. A premature DL (< 4.5 seconds in ≥20% of swallows) defines Distal Esophageal Spasm. If the timing is normal, the final step is to analyze contractile strength.
Step 3: Analyze Peristaltic Strength (DCI) [if IRP and DL are normal]. With normal EGJ relaxation and normal peristaltic timing, the DCI value differentiates between Hypercontractile (Jackhammer) Esophagus, Ineffective Esophageal Motility (IEM), and Absent Contractility.
This systematic, three-step process forms the foundation for accurately classifying the full range of esophageal motility disorders.

3.0 Manometric Classification of Esophageal Motility Disorders
This section systematically details the major esophageal motility disorders as defined by the Chicago v4.0 criteria. For each disorder, this protocol outlines the definitive manometric findings, along with key clinical pearls and common diagnostic pitfalls to guide clinical decision-making.

3.1 Disorders of EGJ Outflow (Elevated IRP)
These disorders are fundamentally characterized by impaired relaxation of the lower esophageal sphincter.
Achalasia Types I, II, and III:
  • Type I (Classic Achalasia): Elevated IRP with minimal esophageal pressurization
  • Type II (Pan-esophageal Pressurization): Elevated IRP with ≥20% of swallows showing pan-esophageal pressurization
  • Type III (Spastic Achalasia): Elevated IRP with ≥20% of swallows showing premature contractions (spastic pattern)
EGJ Outflow Obstruction (EGJOO):
  • Defining HRM Criteria: Elevated IRP with evidence of preserved peristalsis.
  • Diagnostic Pitfall: This is an inconclusive diagnosis based on manometry alone. The finding is often an artifact caused by factors like a hiatal hernia, catheter angulation, or opioid use. It requires confirmation with supportive testing (e.g., timed barium esophagram, EndoFLIP) to verify a true mechanical or functional obstruction before any treatment is considered.

3.2 Disorders of Peristalsis (Normal IRP)
These disorders are characterized by normal LES relaxation but abnormal function of the esophageal body.

Distal Esophageal Spasm (DES):
  • Defining HRM Criteria: Normal IRP with ≥20% of swallows demonstrating premature contractions (DL < 4.5 sec).
  • Clinical Pearl: This is the manometric correlate to a "corkscrew esophagus" seen on a barium swallow. The older term "diffuse esophageal spasm" is conceptually related but has been replaced by this more precise, manometrically-defined diagnosis.
Hypercontractile (Jackhammer) Esophagus:
  • Defining HRM Criteria: Normal IRP with ≥20% of swallows demonstrating a hypercontractile DCI > 8000 mmHg·cm·s.
  • Clinical Pearl: Jackhammer esophagus is a disorder of excessive contractile strength, not premature timing like DES. The obsolete term "nutcracker esophagus" (previously defined as DCI > 5000) has been replaced by this more specific and clinically relevant diagnosis.
Ineffective Esophageal Motility (IEM):
  • Defining HRM Criteria: Normal IRP with either >70% of swallows being weak (DCI < 450 mmHg·cm·s) or ≥50% of swallows being failed.
  • Clinical Pearl: This is the most common manometric abnormality identified, particularly in patients with gastroesophageal reflux disease (GERD). It is not typically a direct target for therapy; management focuses on associated conditions like GERD.
Absent Contractility:
  • Defining HRM Criteria: Normal IRP with 100% failed swallows (DCI < 100 mmHg·cm·s).
  • Clinical Pearl: It is crucial to differentiate the cause. Idiopathic absent contractility presents with a normal IRP. In contrast, Scleroderma Esophagus, a high-yield association for board examinations (often seen in CREST syndrome), is classically defined by absent contractility PLUS a hypotensive LES. This combination leads to profound, severe reflux and its associated complications.

In addition to these manometrically-defined motor disorders, specific behavioral syndromes can also be identified during motility evaluation.

4.0 Diagnosis of Behavioral Esophageal Syndromes
Not all symptoms of esophageal dysfunction stem from primary muscle or nerve pathology. Certain behavioral syndromes can mimic motility disorders and are distinguished by characteristic clinical and manometric features. Their recognition is critical, as they require an entirely different management approach.

4.1 Rumination Syndrome
Clinical Presentation: Patients describe an effortless, non-nauseous regurgitation of recently ingested food into the mouth, typically within minutes of eating. The food is often re-chewed and re-swallowed or spat out.
Characteristic Findings: HRM with impedance reveals a characteristic pattern of an abrupt rise in intra-gastric pressure from somatic abdominal wall contraction, followed by inappropriate LES relaxation and retrograde flow of gastric contents.
Differentiation: This pattern is distinct from vomiting, which is preceded by nausea and retching, and from GERD, which is typically delayed, nocturnal, and involves acidic reflux rather than recently ingested food.

4.2 Supragastric Belching
Clinical Presentation: This syndrome is characterized by repetitive, often socially disruptive belching. The belches originate from air that is unconsciously sucked or aspirated into the esophagus from the pharynx, not from the stomach. The behavior often ceases with distraction or during sleep.
Characteristic Findings: HRM with impedance demonstrates the rapid entry of air into the esophagus from above (the pharynx), followed immediately by its expulsion.
Differentiation: This is distinct from gastric belching, which is the physiologic venting of air from the stomach via a transient LES relaxation.
The correct identification of these syndromes is essential for guiding patients toward appropriate, behavior-focused therapies, which will be detailed alongside treatments for motor disorders in the following section.

5.0 Evidence-Based Treatment Pathways
Treatment strategies for esophageal disorders are highly dependent on the specific diagnosis derived from the comprehensive evaluation. This section organizes therapeutic options by disorder, outlining first-line medical and procedural interventions and their underlying rationales.

Primary Treatment Pathways by Disorder:
Achalasia:
  • First-Line: Pneumatic dilation or laparoscopic Heller myotomy with fundoplication
  • Emerging: Peroral endoscopic myotomy (POEM)
  • Medical: Calcium channel blockers or nitrates (limited efficacy)
  • Botulinum Toxin: Reserved for poor surgical candidates
EGJ Outflow Obstruction (EGJOO):
  • First-Line: Treat underlying cause if identified (hiatal hernia repair, medication adjustment)
  • Confirmatory Testing: Timed barium esophagram, EndoFLIP before intervention
  • Intervention: Only if confirmed functional obstruction
Distal Esophageal Spasm:
  • First-Line: Smooth muscle relaxants (calcium channel blockers, nitrates)
  • Second-Line: Tricyclic antidepressants, SSRIs for pain modulation
  • Procedural: Botulinum toxin injection, rarely pneumatic dilation
Jackhammer Esophagus:
  • First-Line: Smooth muscle relaxants, proton pump inhibitors if concurrent GERD
  • Second-Line: Tricyclic antidepressants for visceral hypersensitivity
  • Procedural: Botulinum toxin injection in refractory cases
Ineffective Esophageal Motility:
  • Primary Focus: Treat associated GERD aggressively
  • PPI Therapy: High-dose, twice-daily dosing
  • Lifestyle: Dietary modifications, positioning
  • Avoid: Prokinetics (contraindicated)
Absent Contractility:
  • Idiopathic: Aggressive GERD management, dietary modifications
  • Scleroderma: Intensive PPI therapy, fundoplication contraindicated
  • Complications: Monitor for strictures, Barrett's esophagus
Rumination Syndrome:
  • First-Line: Behavioral therapy, diaphragmatic breathing exercises
  • Education: Patient education about the voluntary nature
  • Adjunctive: Baclofen in select cases
Supragastric Belching:
  • First-Line: Behavioral modification, speech therapy
  • Distraction Techniques: Cognitive behavioral therapy
  • Avoid: Prokinetics or acid suppression (ineffective)

To reinforce these concepts, the appendix consolidates the highest-yield clinical takeaways and common diagnostic pitfalls encountered in practice and on board examinations.

6.0 Appendix: High-Yield Clinical Pearls and Diagnostic Pitfalls
This section consolidates the most critical, high-yield points and common examination traps related to esophageal motility disorders to reinforce key concepts for clinical practice and board review.

Buzzword and Pitfall Quick Reference:
Classic Associations:
  • "Corkscrew esophagus" on barium swallow = Distal Esophageal Spasm
  • "Bird's beak" appearance = Achalasia
  • CREST syndrome + absent contractility = Scleroderma esophagus
  • "Pseudoachalasia" in elderly = Malignancy until proven otherwise
Common Diagnostic Pitfalls:
  • EGJOO is often artifactual - always confirm with supportive testing
  • Normal endoscopy does not rule out achalasia
  • Scleroderma esophagus = absent contractility + hypotensive LES (not just absent contractility)
  • Jackhammer esophagus is about strength, not timing (unlike DES)
Critical Clinical Pearls:
  • Always scope before diagnosing achalasia
  • IEM is commonly associated with GERD, not a primary target for therapy
  • Behavioral syndromes require behavioral interventions, not medical therapy
  • POEM is emerging as preferred therapy for Type III achalasia
  • Fundoplication is contraindicated in scleroderma esophagus
Manometry in Motility Disorders
Broadcast by